首页> 外文会议>Proceedings of 2011 international symposium - economic transition and development of foreign-funded enterprises >Study on Developing Strategy for Pharmaceutical Enterprises in the Blue Economic Zone of Shandong Peninsula in View of Essential Drug System
【24h】

Study on Developing Strategy for Pharmaceutical Enterprises in the Blue Economic Zone of Shandong Peninsula in View of Essential Drug System

机译:基于基本药物制度的山东半岛蓝色经济区医药企业发展战略研究

获取原文
获取原文并翻译 | 示例

摘要

Essential drug system has deeply affected the development of Chinese pharmaceutical industry. Pharmaceutical market faces great changes of structure. During "the 12th five-year planning ", with the issues of Planning of the Blue Economic Zone of Shandong Peninsula and Reform pilot project of the Blue Economic Zone of Shandong Peninsula, Chinese government proposed development planning of industrial cluster including pharmaceutical industrial cluster, new pharmacy becomes a strategic emerging industry. With the establishment of essential drug system, it urgently needs to be solved that how pharmaceutical enterprises in the Blue Economic Zone of Shandong Peninsula will develop in the future. In this article, the author put forward some developing strategies for pharmaceutical enterprises in the Blue Economic Zone of Shandong Peninsula, combining the Planning of the Blue Economic Zone of Shandong Peninsula with national essential drug system. The author argue there are two kinds of tactics for the pharmaceutical enterprises in essential drug list, including internal development and external development, and the other out of the list should consider the necessity of being in the essential drug list. At last the author argue all pharmaceutical enterprises in the Blue Economic Zone of Shandong Peninsula should try to build large cross-region pharmaceutical industrial cluster and actively participate international competition and cooperation, especially with Japan and South Korea.
机译:基本药物制度深刻影响了中国医药工业的发展。医药市场结构面临巨大变化。在“十二五”期间,随着山东半岛蓝色经济区规划和山东半岛蓝色经济区改革试点问题的提出,中国政府提出了包括医药产业集群在内的产业集群发展规划。药学成为战略性新兴产业。随着基本药物制度的建立,迫切需要解决山东半岛蓝色经济区医药企业未来发展的问题。本文结合山东半岛蓝色经济区规划与国家基本药物制度,提出了山东半岛蓝色经济区医药企业发展战略。作者认为,将药品企业列入基本药物目录有两种策略,包括内部开发和外部开发,另一种策略应考虑纳入基本药物目录的必要性。最后,作者认为山东半岛蓝色经济区的所有制药企业都应尝试建立大型的跨地区制药产业集群,并积极参与国际竞争与合作,特别是与日本和韩国的竞争与合作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号